J&J lifts patent on MDR-TB drug but it may be years before South Africa benefits
Pharmaceutical giant Johnson & Johnson (J&J) recently announced that it would lift patents on the life drug bedaquiline. Bedaquiline is a key component in the cocktail of drugs used to treat multidrug-resistant tuberculosis (MDR-TB) which develops when the TB bacteria…